Bottom line
What is MMRAX's expense ratio?
MMRAX's expense ratio is 0.88%, or about $88 a year on every $10,000 invested. That is cheaper than 53% of allocation / balanced funds we track (median 0.91%). This share class also charges a front-end sales load of up to 3%, taken from your investment when you buy. Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Feb 26, 2026
MMRAX fee table
| Net expense ratio | 0.88% |
|---|---|
| Gross expense ratio | 0.88% |
| Management fee | 0% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.11% |
| Acquired fund fees | 0.52% |
| Fee waiver / reimbursement | 0% |
| Max front-end sales load | 3% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Feb 26, 2026
What MMRAX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| MMRAX | $387 | $572 | $773 | $1,352 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.88% expense ratio costs roughly $49,300 in lost growth, versus about $50,800 for the median allocation / balanced fund (0.91%).